Global Robot-assisted Surgical Devices (RASD) Growth Opportunities, 2021

Global Robot-assisted Surgical Devices (RASD) Growth Opportunities, 2021

Regulatory Approvals, Reimbursement Policies, and Leasing Plans Support Healthcare Centers in Implementing Robotics Surgery

RELEASE DATE
03-Mar-2022
REGION
Global
Research Code: MG5A-01-00-00-00
SKU: HC03515-GL-MT_26338
$4,950.00
In stock
SKU
HC03515-GL-MT_26338
$4,950.00
DownloadLink

Pay by invoice

ENQUIRE NOW

Description

Frost & Sullivan estimates the aging population and accompanying retirements to cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots can mitigate the shortage.

The healthcare sector is forecast to expand rapidly with the decentralization of institutions bringing about more offerings with robotic surgeries. Influenced by the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery with robotic devices with a favorable decline in treatment costs looks promising.

Robotic technology adoption has improved surgeons’ capabilities with better ergonomics, motion scaling, and tremor filtration, meeting their demand. The need for experience before robotic surgery remains debatable. However, the transition from a laparoscopic surgeon to a robotic surgeon is associated with a shorter learning period. Hence, several medical academic and research institutes in the United States and Europe now offer robotic surgery training programs to ensure more surgeons have expertise and skills with a shorter learning curve.

Hospital spending on capital equipment recorded an upswing early in 2021, signaling a stronger outlook for surgical procedures guided by robotic systems for the coming years. Hospital finances seem to be significantly healthier than they were after the economic downturn following the COVID-19 pandemic onset. Frost & Sullivan projects leasing to grow as a percentage of sales over time, with deferred revenue increasing in the future as customers access capital through alternative financing arrangements.

Frost & Sullivan overviews the global robot-assisted surgical devices (RASD) market and revenue forecast from 2022 to 2026, covering a detailed market segment analysis, including various promising and emerging business models. We offer forecast by product (RASD systems, instruments and accessories, RASD services) and region [(North America (NA), Europe, and Asia-Pacific (APAC)].

The study analyzes emerging opportunities and technology trends in surgical robot devices and procedures, with an exclusive focus on technologies enabling different market segments. Frost & Sullivan also details innovations in different segments, initiatives to improve the overall adoption of surgical robotics technologies, and trends that drive and hinder the market growth.

Key Features

The trends shaping the industry are:

  • Increase in Demand for Patient-specific Surgeries: Well-informed patients are demanding surgeons for personalized therapies, implants, procedures, and experience.
  • Demand for Better Procedural Efficiencies: Patients demand maximum comfort while requiring minimum physical supervision. The need of the hour is reducing surgery times, better efficiencies, and optimized outcomes.
  • Changing Reimbursement Trends: The shift toward payments based on quality plus cost over procedure-based reimbursement is likely to change the way medical technologies are evaluated and purchased.
  • Changing Dynamics between Participants: Mergers and acquisitions, joint ventures, and leasing models are forecast to shape the industry.
  • Shift to Emerging Economies: Large orthopedic participants are focusing on Asia-Pacific and other emerging economies that are forecast to register growth rates 2 to 3 times higher than developed markets.
  • Demand for Lesser Hospital Time: The focus shifts to technologies that involve lesser hospital time for patients and lead to quicker recoveries.

Author: Bejoy Daniel


Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the Robot-assisted Surgical Devices Market

Growth Opportunities Fuel the Growth Pipeline Engine™

Segmentation by Application

Technology Overview of the Study

Next Generation Technology and What it Means for Minimal Invasive Surgery

Evolving Roles of Robotics in Surgery

AI Enhances Human-robot Interaction (HRI)

Scope of Analysis

Segmentation by Application

Key Competitors

Key Growth Metrics

Growth Drivers

Growth Restraints

Forecast Assumptions

Revenue Forecast

Revenue Forecast by Product

Revenue Forecast by Region

Revenue Forecast Analysis

Revenue Forecast Analysis (continued)

Forecast Analysis by Region

Pricing Trends and Forecast Analysis

Competitive Environment

Revenue Share

Revenue Share Analysis

Key Growth Metrics

Revenue and Unit Shipment Forecast

Revenue Forecast by Product

Revenue Forecast by Region

Unit Shipment Forecast by Product

Unit Shipment Forecast by Region

Forecast Analysis

Key Growth Metrics

Revenue Forecast

Revenue Forecast by Product

Revenue Forecast by Region

Forecast Analysis

Key Growth Metrics

Revenue Forecast

Revenue Forecast by Region

Forecast Analysis

Evolving Roles of Robotics in Surgery

Recent Advances in Robotic Surgery

AI Enhances HRI

AI for Autonomous Robotic Surgery

Transition from Multi-port to Single-site Surgery

Transition from Multi-port to Single-site Surgery (continued)

Robotic Surgery Becomes the Standard of Care

Adoption Criteria for Robot-assisted Surgery

Comparative Matrix

Comparative Matrix (continued)

Opportunities and Development Scenario by Specialty

RASD Portability

RASD Portability (continued)

Connectivity and Telesurgery

Connectivity and Telesurgery (continued)

Digital Surgery-as-a-Service

Increasing Focus on Microsurgery

Future RASD Market Direction

Growth Opportunity 1—AI for Robotic Surgery to Predict Surgical Outcomes and Minimize Variability

Growth Opportunity 1—AI for Robotic Surgery to Predict Surgical Outcomes and Minimize Variability (continued)

Growth Opportunity 2—Telesurgery enabled with Digital Connectivity to Eliminate Latency

Growth Opportunity 2—Telesurgery enabled with Digital Connectivity to Eliminate Latency (continued)

Growth Opportunity 3—Improved Dexterity to Enable Quick Patient Recovery

Growth Opportunity 3—Improved Dexterity to Enable Quick Patient Recovery (continued)

Growth Opportunity 4—New Pricing Models to Improve Adoption

Growth Opportunity 4—New Pricing Models to Improve Adoption (continued)

Growth Opportunity 5—Simulation and Training for Enhanced Surgical Outcomes

Growth Opportunity 5—Simulation and Training for Enhanced Surgical Outcomes (continued)

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

List of Exhibits (continued)

Legal Disclaimer

Related Research
Frost & Sullivan estimates the aging population and accompanying retirements to cause a significant physician shortfall of 55,000 to 150,000 by 2030, creating a gap in the healthcare system. Expanding the role of autonomous robots can mitigate the shortage. The healthcare sector is forecast to expand rapidly with the decentralization of institutions bringing about more offerings with robotic surgeries. Influenced by the growing incidence of lifestyle diseases and demand for affordable healthcare, effective surgery with robotic devices with a favorable decline in treatment costs looks promising. Robotic technology adoption has improved surgeons’ capabilities with better ergonomics, motion scaling, and tremor filtration, meeting their demand. The need for experience before robotic surgery remains debatable. However, the transition from a laparoscopic surgeon to a robotic surgeon is associated with a shorter learning period. Hence, several medical academic and research institutes in the United States and Europe now offer robotic surgery training programs to ensure more surgeons have expertise and skills with a shorter learning curve. Hospital spending on capital equipment recorded an upswing early in 2021, signaling a stronger outlook for surgical procedures guided by robotic systems for the coming years. Hospital finances seem to be significantly healthier than they were after the economic downturn following the COVID-19 pandemic onset. Frost & Sullivan projects leasing to grow as a percentage of sales over time, with deferred revenue increasing in the future as customers access capital through alternative financing arrangements. Frost & Sullivan overviews the global robot-assisted surgical devices (RASD) market and revenue forecast from 2022 to 2026, covering a detailed market segment analysis, including various promising and emerging business models. We offer forecast by product (RASD systems, instruments and accessories, RASD services) and region [(North America (NA), Europe, and Asia-Pacific (APAC)]. The study analyzes emerging opportunities and technology trends in surgical robot devices and procedures, with an exclusive focus on technologies enabling different market segments. Frost & Sullivan also details innovations in different segments, initiatives to improve the overall adoption of surgical robotics technologies, and trends that drive and hinder the market growth.--BEGIN PROMO--

Key Features

The trends shaping the industry are:

  • Increase in Demand for Patient-specific Surgeries: Well-informed patients are demanding surgeons for personalized therapies, implants, procedures, and experience.
  • Demand for Better Procedural Efficiencies: Patients demand maximum comfort while requiring minimum physical supervision. The need of the hour is reducing surgery times, better efficiencies, and optimized outcomes.
  • Changing Reimbursement Trends: The shift toward payments based on quality plus cost over procedure-based reimbursement is likely to change the way medical technologies are evaluated and purchased.
  • Changing Dynamics between Participants: Mergers and acquisitions, joint ventures, and leasing models are forecast to shape the industry.
  • Shift to Emerging Economies: Large orthopedic participants are focusing on Asia-Pacific and other emerging economies that are forecast to register growth rates 2 to 3 times higher than developed markets.
  • Demand for Lesser Hospital Time: The focus shifts to technologies that involve lesser hospital time for patients and lead to quicker recoveries.

Author: Bejoy Daniel

More Information
No Index No
Podcast No
Author Bejoy Daniel
Industries Healthcare
WIP Number MG5A-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9A4B-B1